Nassiri, F., Herold-Mende, C., Sahm, F., & Deimling, A. v. (2019). DNA methylation profiling to predict recurrence risk in meningioma: Development and validation of a nomogram to optimize clinical management. Neuro-Oncology, 21(7), . https://doi.org/10.1093/neuonc/noz061
Chicago-Zitierstil (17. Ausg.)Nassiri, Farshad, Christel Herold-Mende, Felix Sahm, und Andreas von Deimling. "DNA Methylation Profiling to Predict Recurrence Risk in Meningioma: Development and Validation of a Nomogram to Optimize Clinical Management." Neuro-Oncology 21, no. 7 (2019). https://doi.org/10.1093/neuonc/noz061.
MLA-Zitierstil (9. Ausg.)Nassiri, Farshad, et al. "DNA Methylation Profiling to Predict Recurrence Risk in Meningioma: Development and Validation of a Nomogram to Optimize Clinical Management." Neuro-Oncology, vol. 21, no. 7, 2019, https://doi.org/10.1093/neuonc/noz061.